Non-Invasive Prenatal Testing Market Expected to Reach $10.54 Billion by 2031 Driven by Rising Maternal Age and Advancements in Screening Technologies

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Non-Invasive Prenatal Testing Market By Method (Ultrasound Detection, Biochemical Screening Tests, Cell-Free DNA In Maternal Plasma Tests And Others), End-User (Diagnostic Laboratories, Hospitals, Research Centres And Clinics.), Application (Trisomy, Microdelection Syndrome And Others)- Trends, Industry Competition Analysis, Revenue And Forecast To 2030."

The global non-invasive prenatal testing market is estimated to reach over USD 10.54 billion by 2031, exhibiting a CAGR of 12.33% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1425

Non-invasive prenatal testing (NIPT), also known as non-invasive prenatal screening, is a technique used to evaluate the likelihood of genetic disorders in a fetus. This method is highly effective and poses no risk to the mother or fetus. It is commonly used to detect chromosomal abnormalities such as Down syndrome, Patau syndrome, Edwards syndrome, and Turner syndrome. The procedure involves analyzing small fragments of fetal DNA circulating in the maternal bloodstream, which can be detected as early as the 10th week of pregnancy.

The market for non-invasive prenatal testing is experiencing significant growth, primarily driven by the increasing prevalence of chromosomal abnormalities and the rising maternal age. The probability of genetic disorders increases with maternal age, particularly in pregnancies beyond the age of 35. Consequently, obstetricians are increasingly recommending NIPT to ensure healthy deliveries, thereby contributing to market expansion.

Furthermore, advancements in technology are enhancing the cost-effectiveness of non-invasive prenatal testing, which is expected to further accelerate market growth in the coming years. Increased research and development (R&D) efforts aimed at developing innovative testing methods are also expected to drive market expansion. Additionally, growing government funding to support R&D in the field of non-invasive prenatal testing is anticipated to create favorable conditions for market growth.

List of Prominent Players in the Non-Invasive Prenatal Testing Market:
Yourgene Health
Illumina Inc.
Agilent Technologies Inc.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
Laboratory Corporation of America Holdings
GE Healthcare
PerkinElmer Inc.
BGI
Natera Inc.

Market Dynamics:
Drivers-
The development of highly advanced screening methods with enhanced sensitivity and accuracy for the early detection of genetic abnormalities in newborns remains a key focus for numerous companies. Manufacturers are prioritizing the advancement of innovative non-invasive prenatal diagnostic solutions while actively pursuing strategic partnerships and collaborations to strengthen their market position. Moreover, the adoption of non-invasive prenatal testing is expected to rise during the forecast period, supported by favorable reimbursement policies and growing awareness of the benefits of non-invasive methods compared to traditional invasive prenatal diagnostics.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Challenges
The adoption of non-invasive prenatal testing (NIPT) is expected to be limited by its high cost, which renders it relatively unaffordable in many developing countries. According to a report by Future Medicine, the average cost of NIPT in India ranges from USD 350 to USD 400, which has hindered its acceptance in emerging markets. Additionally, the general lack of awareness regarding the risks of genetic disorders in developing regions further constrains market growth. Moreover, low per capita healthcare spending and inadequate reimbursement policies for these tests are additional factors that could impede the expansion of the global non-invasive prenatal testing market.

Regional Trends
The North American non-invasive prenatal testing market is anticipated to secure a substantial market share in terms of revenue and is projected to grow at a high compound annual growth rate (CAGR) in the near term. This growth is driven by an increasing prevalence of genetic disorders at birth, the demand for advanced screening methods, and rising reimbursement coverage for pregnancy-related risks. Research conducted by the Health Expense Institute indicates that the North American NIPT market will benefit from the average annual healthcare expenditure of USD 4,879.0 per child in the United States. Furthermore, the strategic focus of major market players on expanding their product portfolios is significantly contributing to market growth and increased demand for NIPT.

The Asia Pacific non-invasive prenatal testing market also held a significant share, driven by the increasing incidence of chromosomal aneuploidies in newborns and rising maternal age, which have expanded the potential customer base. Technological integration of next-generation sequencing (NGS) methods, substantial advancements in China and Japan, and improvements in healthcare infrastructure are expected to support continued market expansion across the region.

Recent Developments:
• In July 2021, Pacific Biosciences and Omniome, a San Diego-based business, inked a binding merger agreement. This partnership will increase sequencing opportunities and benefit customers through creative market expansion strategies.
• In June 2021, VeriSeq NIPT Solution v2 was introduced in Thailand by Illumina, Inc. and Next-Generation Genomic Co., Ltd. End-to-end genome-wide non-invasive prenatal testing is available with VeriSeq NIPT Solution and is accurate, dependable, scalable, and quick.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1425

Segmentation of Non-Invasive Prenatal Testing Market-
By Method-
• Ultrasound Detection
• Biochemical Screening Tests
• Cell-free DNA in Maternal Plasma Test
• Others
By End-Use-
• Diagnostic Laboratories
• Hospitals
• Research Centers
• Clinics
By Application-
• Trisomy
• Microdelection Syndrome
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.